In an upright film, an air-fluid level is easily recognizable, and is thought to denote acute disease-- or an acute exacerbation of chronic sinusitis, when it coexists with mucosal thickening.

These are the first placebo-controlled clinical trials to show that medication reduces subjective symptoms and objective measures of sinus disease for patients with chronic sinusitis, both with and ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

When your immune system is already fighting off a disease (such as a cold), it ... medications and at-home treatments may ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Known as Aspirin-Exacerbated Respiratory Disease (AERD), this condition is marked by a combination ... to determine if a ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis ... vice chair of ...

Six months after Amgen and AstraZeneca reported promising results for Tezspire (tezepelumab) as a potential treatment for ...

A study published in Frontiers in Medicine reveals that chronic rhinosinusitis with and without nasal polyps is closely correlated with asthma.A study was done to investigate the ...

The Rhinology and Sinus Surgery Program provides comprehensive care for inflammatory, infectious, and neoplastic diseases of the sinus and nasal ... novel treatment strategies for chronic ...

Adults 50 and older can now get the shot, as rates of the illness climb. The Centers for Disease Control and Prevention has ...